The CEO's ~$18.9M sale is the dominant signal, it is large, concentrated, and not offset by any insider buying. While the sales follow option exercises (tax-driven), the sheer size and timing suggest potential caution. Monitor for any upcoming clinical data readouts, earnings, or financing events that could explain the selling. The 95% bullish analyst consensus creates a potential asymmetry if negative news emerges.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 12 $112.41entry
- T+1 · 3mo ago −2.50%α −3.20% · $109.60
- T+5 · 3mo ago +1.15%α +1.59% · $113.70
- T+20 · 2mo ago −8.12%α −6.22% · $103.28
- T+60 · 12d ago −26.15%α −21.04% · $83.01
Price Chart
How similar events traded
Executive Summary
CEO Marino Garcia and General Counsel Adam Veness executed a cluster of open-market sales totaling ~$20.0M over two days (Aug 7-10, 2026), following option exercises at much lower strike prices. The CEO alone sold ~$18.9M at ~$108-111/share, while the GC sold ~$2.2M. These are large, concentrated sales by top executives at a $6.3B biotech with a 95% bullish analyst consensus, creating a notable bearish signal that warrants close monitoring.
Key Financial Metrics
Key Facts
- CEO Marino Garcia sold 166,000 shares in open-market transactions on Aug 7, 2026, totaling ~$18.9M at prices between $107.49 and $110.76.
- General Counsel Veness sold 20,000 shares on Aug 7 and 10, 2026, totaling ~$2.2M at prices between $110.38 and $111.18.
- All sales followed option exercises: CEO exercised 292,000 options at $0-$8.44 strike; GC exercised 23,833 options at $0-$17.88 strike.
- Total open-market sales by the two insiders in the cluster: ~$20.0M, representing approximately 0.32% of DNTH's $6.3B market cap.
- The cluster occurred within a 7-day window (Aug 7-10), with no open-market purchases by any insider.
- DNTH has a 95% bullish analyst consensus (21 Buy, 1 Hold) and $6.3B market cap.
Financial Impact
Insider sales of ~$20.0M represent 0.32% of market cap, modest in proportionality but significant in absolute dollar terms and executive seniority.
Risk Factors
- CEO selling ~$18.9M in a concentrated window could signal management's view that the stock is fully valued or that near-term catalysts are uncertain.
- No insider buying to offset the selling, the cluster is entirely one-directional (sell).
- Biotech stocks are binary event-driven, large insider sales ahead of data readouts can be a red flag.
- The stock has rallied significantly (options exercised at $8.44 vs. sale price ~$108), creating a natural profit-taking incentive.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-DNTH-1786482561581 |
Track record
23 reports on DNTH
6 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +41.40% at T+60 after the Jun 11, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $89.76 Now $89.55 −0.23% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $88.81 to $89.30 Now $89.55 +0.83% ▲ +0.55% −0.77% vs SPY
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $83.01 to $86.03 Now $89.55 +7.88% ▲ +3.64% +3.33% vs SPY
- Oct 30, 202617d ago Institutional Cluster Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
- Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $81.57 to $77.58 Now $89.55 +9.78% ▼ −4.89% −4.88% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 4/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers